Medi-Rent Pty Ltd - DS Maref LX9 Sequential Pneumatic Compression Device Recall

A recall notice for DS Maref LX9 Sequential Pneumatic Compression Device supplied by Medi-Rent Pty Ltd as a fault in the programming of the LX9 pumps, may cause users to experience higher pressure in the garments than set on the device.

Medi-Rent Pty Ltd - DS Maref LX9 Sequential Pneumatic Compression Device

PRA number

2021/19283

Published date

24 Nov 2021

Product description

DS Maref LX9 Sequential Pneumatic Compression Device

Serial numbers: 220112944 to 20117954 and 2026322 to 2032792

ARTG 206228
(Medi-Rent Pty Ltd - Compression unit, sequential)

Sequential Intermittent Pneumatic Compression (SIPC) therapy is the process of applying external pressure to the limbs to promote the circulation of blood and lymphatic fluid from the extremities of the body.

Photograph of LX9 pump

Photograph of Medi-rent LX9 arm garment

Photograph of Medi-rent LX9 leg garment

Photograph of Medi-rent LX9 body garment

What are the defects?

A fault in the programming of the LX9 pumps, may cause users to experience higher pressure in the garments than set on the device.

What are the hazards?

If the pressure in the garments becomes excessive for the user and exceeds the devices pressure specifications, this could result in an increased risk of health complications.

What should consumers do?

Medi-Rent will update the programming on all pumps which have been programmed with software version 2020.11.01, which will correct the issue.

In the interim, consumers are advised to follow the instructions in the customer letter for use of the device until the reprogramming is complete.

For further information, contact Medi-Rent by phone on 1300 726 666.

Supplier

Medi-Rent Pty Ltd

Traders who sold this product

Hospital and health services in ACT, NSW, SA, Qld, Vic and WA

Where the product was sold

International

Online

New South Wales

Queensland

South Australia

Victoria

Western Australia

Australian Capital Territory

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category

Pharmacy

Personal